A nurse is caring for a patient with obsessive-compulsive disorder (OCD). The nurse understands that the pharmacological treatment for OCD often involves the use of which of the following medications? (Select all that apply.)

Choice A rationale:

Completely eliminate anxiety symptoms. While this might be an ideal goal, it's not always achievable due to the nature of anxiety disorders. Anxiety is a normal human emotion, and the goal of treatment is to manage it rather than eliminate it completely.

Choice B rationale:

Reduce the severity and frequency of anxiety symptoms. This is the correct goal of pharmacological treatment for anxiety disorders. Complete elimination of anxiety symptoms is often unrealistic, but reducing their severity and frequency can significantly improve the patient's quality of life.

Choice C rationale:

Treat the underlying cause of anxiety disorders. Anxiety disorders are multifactorial, involving genetic, environmental, and psychological factors. While addressing underlying causes is important, pharmacological treatment primarily aims to manage symptoms rather than target the complex underlying causes.

Choice D rationale:

Prevent comorbidities associated with anxiety disorders. While effective anxiety treatment can potentially prevent some comorbidities, such as depression, the primary focus of pharmacological treatment is directly on managing anxiety symptoms rather than solely preventing associated conditions.

Choice A rationale:

Enhance the activity of gamma-aminobutyric acid (GABA) in the brain. Benzodiazepines are known to enhance the inhibitory effects of GABA, the major inhibitory neurotransmitter in the central nervous system. This results in reduced neuronal excitability, leading to the anxiolytic (anxiety-reducing) effects of benzodiazepines.

Choice B rationale:

Block beta-adrenergic receptors in the heart and blood vessels. This statement is incorrect. While beta-blockers can be used to manage certain physical symptoms of anxiety (such as rapid heartbeat), benzodiazepines do not directly block beta-adrenergic receptors.

Choice C rationale:

Partially agonize serotonin 5-HT1A receptors and antagonize dopamine D2 receptors. This statement is inaccurate. Benzodiazepines primarily interact with GABA receptors, not serotonin or dopamine receptors.

Choice D rationale:

Modulate the activity of various neurotransmitters and ion channels in the brain. This statement is overly broad and doesn't accurately describe the specific mechanism of benzodiazepines. Their primary mode of action is through enhancing GABAergic inhibition.